Oryzon Genomics' Unattributed VC Round

Oryzon Genomics raised a round of funding on October 27, 2015.

Oryzon Genomics is a privately held, clinical stage biopharmaceutical company. Its LSD1 program is covered by 18 patent families and has rendered one compound in clinical trials and another one to ent…

Articles about Oryzon Genomics' Unattributed VC Round: